- Debts << Assets - NOLs - Patents, R&D & Trade secrets - Contracts - Not bankrupt - Best interest of ultimate shareholders.
The rest is just noise.
However, by the logic of some here, retail shareholders will lose all their investment while institutional shareholders were paid off secretly.
Let's ask what the Canadian & US judges say to that logic and ask Mitsui what they received in return for handing over their Bioamber patents to LCY. Hint: not $1.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.